Presentation on theme: "AstraZeneca in Algeria Driven by Science, Serving Patients"— Presentation transcript:
1AstraZeneca in Algeria Driven by Science, Serving Patients Habib BennaceurNorth West Africa President10th December 2014
2AstraZeneca is present in Algeria since 2006 AstraZeneca in Algeria - We push the boundaries of science to deliver life-changing medicinesAstraZeneca is present in Algeria since 2006170 employees AstraZeneca provides Algerian patients with multiple important molecules, particularly in Oncology, Cardiovascular, Respiratory and Gastrointestinal.
3AstraZeneca as an active partner in developing people in Algeria: Our priorities Patient support educationR&D capabilitiesLocal manufacturing and technology transferHealth Care Professional skillsAstraZeneca Algeria as best place to work
4AstraZeneca Algeria at a Glance : Opportunities and Challenges LanguageInternational experienceTurnoverYoung populationDiversityEducationeconomical and political stabilityLong term presenceScarcity & competition for talents with rising manpower costs to attract &retain the bestLack of International experienceNew people managers mainly, internally promoted
5AstraZeneca Algeria long term commitment Ministry of HealthMedical Scientific SocietiesPatient AssociationsPublic HealthPatient First- Patient support program- Patient educators for chronic diseasesPartneringFor Scientific Leadership- R&D (ATLANTIC, ESMAA).- CME- Partnerships with International academiesEmployeesGreat Place to WorkWe engage and inspire AstraZeneca employees about our commitment to addressing urgent public health threatsJVAZ Algeria industrial Foot PrintToll manufacturingCollaboration with SAIDAL
6AZ Algeria Oncology plan - Five pillars Supporting Algerian Government Strategy Assessment of Cancer centers and send recommendation to reach international standardsHave 1 or 2 centers accredited by Karolinska or Gustavo RoussyNational cancer registries implementationSupport R&DImplement strong screening program for Breast/Prostatic/ Colon cancerWork on “Phakamisa” modelKc screening andpreventionValidate EGFR Plateform by Karolinska centerExpand diagnosis capabilities to other mutations typeDevelop “Microbiologists” capabilitiesEnhance DiagnosisplateformAssess GPs role in prevention/Screening/Follow up of the patientsSupport GPs training in OncologyWork on “Oncology Network” developmentBuild HCP Network & training*based on data presented at January 2014 JP Morgan Conference.Provide Nurses and Psychologists at home for palliative treatmentsPatient support program
7Algeria - Headquarter for North West African countries TinisiaMorocoWesterne SaharaMauritaniaSenegalGambiaMaliGuiniaCote d’IvoireChadCent- African-RpCameroomDemoc-Rp- CongoCongoGabonNigerBeninTogo